Sutro Biopharma STRO Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's change in AP?
- Sutro Biopharma (STRO) reported change in AP of -$2.55M in Q1 2026.
- How has Sutro Biopharma's change in AP changed year-over-year?
- Sutro Biopharma's change in AP decreased by 35.4% year-over-year, from -$1.88M to -$2.55M.
- What is the long-term trend for Sutro Biopharma's change in AP?
- Over 2 years (2022 to 2024), Sutro Biopharma's change in AP has grown at a -24.1% compound annual growth rate (CAGR), from -$1.23M to $706K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.